Use of Intrapyloric Botulinum Injections in Children

Status Recruiting

Clinical Trial Summary

This study aims to evaluate the effect of intrapyloric botulinum toxin in children with feeding disorders.

Clinical Trial Description

Chronic vomiting and feeding difficulties are common in young children and have a negative physical and psychosocial impact for patients and families. Currently there is no straightforward treatment algorithm for these issues, and management often involves multiple medication trials and procedures. Intrapyloric botulinum toxin injection has been proposed as a treatment for nausea and vomiting in adults, but there is minimal prior research on use in children and no prior research on use in children with feeding disorders. The aims of this study are: (1) to determine the efficacy of intrapyloric botulinum toxin injection for reducing gastrointestinal symptoms in children, (2) to determine the efficacy of intrapyloric botulinum injections for improving feeding outcomes in children, and (3) to define predictors of response to intrapyloric botulinum toxin injection. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04250844
Study type	Observational
Source	Boston Children's Hospital
Contact	Suzanna Hirsch, MD
Phone	617-355-6058
Email	suzanna.hirsch@childrens.harvard.edu
Status	Recruiting
Phase
Start date	March 10, 2020
Completion date	May 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00358813` - Observational Pharmacokinetic Study Of GW679769 In Subjects With Renal Impairment	Phase 1
Recruiting	`NCT03851835` - Multi-DOSE Oral Ondansetron for Pediatric Acute GastroEnteritis	Phase 3
Terminated	`NCT01649258` - Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients With Breast Cancer Undergoing Chemotherapy	Phase 1
Terminated	`NCT01975727` - Dexamethasone for the Treatment of Established Postoperative Nausea and Vomiting	Phase 2
Completed	`NCT02939287` - Aprepitant- and Olanzapine- Containing Anti-emetic Regimens With High Dose Melphalan	Phase 3
Not yet recruiting	`NCT06464926` - Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System (NAVIGATE)	N/A
Completed	`NCT02462811` - A Double-Blind, Randomized, Active- and Placebo-Controlled, Multiple-Dose Multi-Center Phase 3 Study of the Safety and Efficacy of CL-108 in the Treatment of Moderate to Severe Acute Pain and Opioid-Induced Nausea and Vomiting (OINV)	Phase 3
Recruiting	`NCT01966406` - Is Nasogastric Tube Necessary After Pancreaticoduodenectomy?	N/A
Completed	`NCT01007500` - Effect of Dexamethasone Combined With Ondansetron on Postoperative Nausea and Vomiting in Patients With Patient-controlled Analgesia After Video-assisted Thoracoscopic Surgery	Phase 4
Recruiting	`NCT00528554` - Laser Acupuncture Against Nausea in Children	N/A
Completed	`NCT00537875` - Evaluation of the Effect of Zingiber Officinalis on Nausea and Vomiting in Patients Receiving Cisplatin Based Regimens	N/A
Completed	`NCT00394966` - A Multicenter, Randomized, Controlled Trial of SCH 619734 for the Treatment of Chemotherapy-Induced Nausea and Vomiting (Study P04351AM2)(COMPLETED)	Phase 2
Completed	`NCT00177333` - Serum Levels of Doxycycline at the Time of Abortion With Two Dosing Regimens	Phase 4
Completed	`NCT00946387` - To Demonstrate the Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Fasting Conditions	Phase 1
Completed	`NCT00947128` - To Demonstrate the Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Non-Fasting Conditions	Phase 1
Not yet recruiting	`NCT04827108` - Psychometric Properties of the Chinese Version of PeNAT
Not yet recruiting	`NCT04853303` - VR to Improve CINV, Sleep and Pain Among Children With Cancer in HK	N/A
Recruiting	`NCT03679182` - Efficacy and Safety of Olanzapine for the Treatment of Nausea and Vomiting in Palliative Cancer Care	Phase 2
Terminated	`NCT01405924` - Fosaprepitant (MK-0517, EMEND® IV) In Salvage Treatment of Chemotherapy-Induced Vomiting (MK-0517-030)	Phase 2
Recruiting	`NCT04116697` - A Randomized Controlled Trial to Evaluate the Efficacy of Acupuncture Versus Aromatherapy as Treatments to Lessen Nausea, Vomiting and Anxiety Associated With Adriamycin and Cytoxan	N/A